VeriChip Corporation has selected Raytheon Microelectronics España/ECLAN for the production of the company’s implantable microchips, including the chip used in its HealthLink patient identification system, its new eight millimeter microchip for use in Medical Components Inc.’s vascular access medical devices, and its glucose-sensing RFID microchip under development with RECEPTORS LLC.
In December 2008, VeriChip purchased all intellectual property related to its implantable RFID business line from Digital Angel Corporation and canceled its manufacturing relationship. After searching for a new manufacturing partner, VeriChip landed on ELCAN Optical Technologies, a provider of optical and electronic solutions for medical, defense & security and commercial customers, and part of the Raytheon Network Centric Systems group of companies.
Latest from Today's Medical Developments
- Boston Scientific to acquire Penumbra, expanding cardiovascular portfolio
- Star Cutter introduces Double Pilot Reamer
- #80 Manufacturing Matters - Machining Strategies to Save Time and Improve your Process for MedTech Components with Kennametal Inc.
- Real-world parts and expert manufacturing advice
- Experts discuss the latest in toolholding technology
- How permanent magnets are powering medical innovation
- Forecasting the year ahead in design and manufacturing
- Tecomet, Orchid Orthopedic Solutions announce merger agreement
